Acute toxicity of neoadjuvant bolus 5-FU/methotrexate and leucovorin rescue followed by continuous infusion 5-FU plus pre-operative radiation therapy for rectal cancer
- 1 January 1996
- journal article
- research article
- Published by Wiley in Radiation Oncology Investigations
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer.Journal of Clinical Oncology, 1995
- Sphincter preservation with preoperative radiation therapy and coloanal anastomosisInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative SurgeryNew England Journal of Medicine, 1994
- Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinomaAnnals of Surgical Oncology, 1994
- Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancerCancer, 1994
- Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable recta cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Fluoropyrimidines as radiation sensitizersSeminars in Radiation Oncology, 1993
- Pelvic radiation therapy in rectal cancer: Technical considerationsSeminars in Radiation Oncology, 1993
- Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.Journal of Clinical Oncology, 1992
- Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancerCancer, 1991